Sign in

Lewy body dementia: trials that stopped early

Trials on Lewy body dementia that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.

Stopped early

3 stopped trials give a reason in the registry, latest registry update first.

  1. Terminated

    K0706 for Patients Diagnosed With Dementia With Lewy Bodies

    Reason given in the registry

    “Interim analysis was performed for 442 patients who completed Part I of the PROSEEK study-(CLR\_18\_06); it did not show evidence of treatment benefit in patients receiving Vodobatinib.”

    Quoted unchanged from ClinicalTrials.gov; record updated 8 Jun 2026.

    Ended
    Apr 2024
    Phase
    Phase 2
    Run by
    Georgetown University
    Registry record
    NCT03996460
  2. Withdrawn

    A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia

    Reason given in the registry

    “Study withdrawn and being modified under another protocol”

    Quoted unchanged from ClinicalTrials.gov; record updated 17 Nov 2022.

    Ended
    Dec 2024
    Run by
    Mayo Clinic
    Registry record
    NCT05497817
  3. Withdrawn

    Biomarkers in Neurodegenerative Diseases

    Reason given in the registry

    “Lack of regulatory approval”

    Quoted unchanged from ClinicalTrials.gov; record updated 12 Nov 2019.

    Ended
    Oct 2025
    Run by
    University of Minnesota
    Registry record
    NCT04055532

Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.